Explorer›Medicine›Open Science
Research PaperResearchia:202610.08065

The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019

Nick J Andrews

Abstract

The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019 --- Source: OpenAlex - Vaccine (Citations: 1) PDF: https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf Original Link: https://doi.org/https://doi.org/10.1016/j.vaccine.2026.129168

Submitted: October 8, 2026Subjects: Open Science; Medicine

Description / Details

The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019

Source: OpenAlex - Vaccine (Citations: 1) PDF: https://www.sciencedirect.com/science/article/pii/S0264410X26009771/pdf Original Link: https://doi.org/https://doi.org/10.1016/j.vaccine.2026.129168

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Oct 8, 2026
Topic:
Medicine
Area:
Open Science
Comments:
0
Bookmark
The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000–2019 | Researchia